Papers/PMID:21633597
(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
World journal of gastroenterology2011The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
(-)-epigallocatechin 3-gallate — inhibits STAT3
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“EGCG dose-dependently inhibited Stat3 activation induced by IL-6, but did not change the total Stat3 expression.”
Quoted verbatim from (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.. - Study
- in vitro · not in humans
- Population
- Human gastric cancer (AGS) cells stimulated with IL-6 (50 ng/mL) and treated with EGCG at different concentrations
(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.2011PMID:21633597Permalink